<DOC>
	<DOC>NCT00909311</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of food on pharmacokinetics, safety and tolerability of an experimental Hepatitis C Virus (HCV) protease inhibitor with ritonavir in healthy volunteers.</brief_summary>
	<brief_title>Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir</brief_title>
	<detailed_description>This is an open-label, randomized, 2 cross-over period fasting and non-fasting study.</detailed_description>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>overall healthy subjects; nonchildbearing potential females included history of significant sensitivity to any drug; positive test for HAV IgM, HBsAg, antiHCV Ab or antiHIV Ab; history of gastrointestinal issues or procedures; history of seizures, diabetes or cancer (except basal cell carcinoma); clinically significant cardiovascular, respiratory (except mild asthma), renal, gastrointestinal, hematologic, neurologic, thyroid, or any uncontrolled medical illness or psychiatric disorder; use of tobacco or nicotinecontaining products with the 6month period prior to study drug administration; donation or loss of 550 mL or more blood volume or receipt of a transfusion of any blood product within 8 weeks prior to study drug administration; abnormal screening laboratory results that are considered clinically significant by the investigator; current enrollment in another clinical study; previous enrollment in this study; recent (6month) history of drug/alcohol abuse that could preclude adherence to the protocol; pregnant or breastfeeding female; requirement for any OTC and/or prescription medication, vitamins and/or herbal supplements on a regular basis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Food effect</keyword>
</DOC>